ZEO Scientifix Inc.
01/21/2026 | Press release | Distributed by Public on 01/21/2026 16:18
Management Change/Compensation (Form 8-K)
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January 14, 2026, the Company awarded 175,000 restricted shares of our common stock ("Shares") under our 2021 Incentive Stock Plan to each of Ian Bothwell, our Chief Executive Officer and Chief Financial Officer and a member of the board of directors and Dr. George Shapiro, our Chief Medical Officer and a member of the board of directors. The Shares vest 50% on the eighth month anniversary of the award date and the remaining 50% on the one-year anniversary.
ZEO Scientifix Inc. published this content on January 21, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 21, 2026 at 22:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]